|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Prepaid interest and deposits | ||||||||||||||||||||
| Advances | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Advances | ||||||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $8,373 and $0 on September 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||||
| Advances made for Iinventory purchases | ||||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||||
| Property and equipment, net of depreciation | ||||||||||||||||||||
| Intangible assets, net of accumulated amortization of $157,930 and $886,911 on September 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Bank overdraft | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Unsecured notes and accrued interest payable | ||||||||||||||||||||
| Convertible notes and accrued interest - net of debt discount | ||||||||||||||||||||
| Convertible notes and accrued interest - related party | ||||||||||||||||||||
| Secured Promisory Notes and Accrued Interest | ||||||||||||||||||||
| Secured Promissory Notes and Accrued Interest | ||||||||||||||||||||
| Promissory Notes and Accrued Interest | ||||||||||||||||||||
| Promissory note and accrued interest - related party | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Self Liquidating Promissory Notes | ||||||||||||||||||||
| Subscription payable | ||||||||||||||||||||
| Current liabilities from discontinued operations | ||||||||||||||||||||
| Advances from related parties | ||||||||||||||||||||
| Related party loans and accrued interest | ||||||||||||||||||||
| Self-Liquidating Promissory Notes | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series B Preferred Shares | ||||||||||||||||||||
| Series C Preferred Shares | ||||||||||||||||||||
| Series D Preferred Shares | ||||||||||||||||||||
| Series Z Preferred Shares | ||||||||||||||||||||
| Class B Preferred Stock Member | ||||||||||||||||||||
| Class C Preferred Stock Member | ||||||||||||||||||||
| Class D Preferred Stock Member | ||||||||||||||||||||
| Class Z Preferred Stock Member | ||||||||||||||||||||
| Series F Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series C, Preferred Stock | ||||||||||||||||||||
| Series Z Preferred Stock | ||||||||||||||||||||
| Total preferred stock, value | ||||||||||||||||||||
| Common stock $0.001 par value, 2,500,000,000 shares authorized, 2,335,501,281 and 2,262,255,848 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||||
| Common stock issuable | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY (DEFICIENCY) | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) | ||||||||||||||||||||
Loading...
